Specific Immunosuppressive Therapy by Monoclonal Anti-IL 2 Receptor Antibody and Its Synergistic Action with Cyclosporin
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Immunobiology
- Vol. 172 (3-5), 391-399
- https://doi.org/10.1016/s0171-2985(86)80120-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Suppression of T-Cell Mediated Autoimmune Disease with Antibodies against the Interleukin-2 Receptor Effect of Hybridoma ART-18 on T Line Mediated Experimental Autoimmune EncephalomyelitisAnnals of the New York Academy of Sciences, 1986
- Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.Proceedings of the National Academy of Sciences, 1986
- Suppression of the local graft‐vs.‐host reaction in ratsby treatment with a monoclonal antibody specific for the interleukin 2 receptorEuropean Journal of Immunology, 1986
- Studies on interleukin 2 receptor expression and IL-2 production by murine T cell lymphomasBritish Journal of Cancer, 1985
- Studies on the interleukin-2 receptor, its generation and dynamics using monoclonal anti-interleukin-2 receptor antibodiesMolecular Immunology, 1984
- Experience with Cyclosporine and Steroids in Clinical Renal TransplantationAnnals of Surgery, 1984
- SPARING OF SUPPRESSOR CELLSTransplantation, 1984
- Functions of Rat T‐Lymphocyte Subsets Isolated by Means of Monoclonal AntibodiesImmunological Reviews, 1983